Category : Orthopedic Oncology / Orthopaedics
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel combination therapy that significantly improves treatment outcomes and survival in patients with acute myeloid leukemia (AML) with FLT3 gene mutations.
Source : Medical Xpress
On : 19-Jun-2026